Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
5.00
-0.15 (-2.91%)
Mar 31, 2025, 3:53 PM EDT - Market open
Cara Therapeutics Market Cap
Cara Therapeutics has a market cap or net worth of $22.87 million as of March 31, 2025. Its market cap has decreased by -51.96% in one year.
Market Cap
22.87M
Enterprise Value
30.10M
1-Year Change
-51.96%
Ranking
Category
Stock Price
$5.00
Market Cap Chart
Since January 31, 2014, Cara Therapeutics's market cap has decreased from $282.00M to $22.87M, a decrease of -91.89%. That is a compound annual growth rate of -20.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 23.60M | -15.71% |
| Dec 31, 2024 | 28.00M | -30.86% |
| Dec 29, 2023 | 40.50M | -92.98% |
| Dec 30, 2022 | 577.10M | -11.37% |
| Dec 31, 2021 | 651.10M | -13.65% |
| Dec 31, 2020 | 754.00M | 0.27% |
| Dec 31, 2019 | 752.00M | 46.65% |
| Dec 31, 2018 | 512.80M | 28.49% |
| Dec 29, 2017 | 399.10M | 57.44% |
| Dec 30, 2016 | 253.50M | -44.78% |
| Dec 31, 2015 | 459.10M | 102.16% |
| Dec 31, 2014 | 227.10M | -19.47% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |